Clinical Trials Directory

Trials / Conditions / Mild to Moderate COVID-19

Mild to Moderate COVID-19

12 registered clinical trials studyying Mild to Moderate COVID-19.

StatusTrialSponsorPhase
CompletedA Study to Evaluate the Efficacy, Safety, and Concentration of SNS812 in Mild to Moderate COVID-19 Patients
NCT05941793
Oneness Biotech Co., Ltd.Phase 2
CompletedPhase III Clinical Study Evaluating the Efficacy and Safety of WPV01 in Patients With Mild/Moderate COVID-19
NCT06197217
Westlake Pharmaceuticals (Hangzhou) Co., Ltd.Phase 3
UnknownEvaluate the Efficacy and Safety of FB2001 for Inhalation in Patients With Mild to Moderate COVID-19
NCT05675072
Frontier Biotechnologies Inc.Phase 2 / Phase 3
CompletedStudy of RAY1216 Tablets Compared With Placebo in Patients With Mild to Moderate COVID-19
NCT05620160
Guangdong Raynovent Biotech Co., LtdPhase 3
CompletedJT001 (VV116) for the Treatment of COVID-19
NCT05582629
Shanghai Vinnerna Biosciences Co., Ltd.Phase 3
TerminatedJT001 (VV116) for the Early Treatment of COVID-19
NCT05242042
Shanghai JunTop Biosciences Co., LTDPhase 2 / Phase 3
UnknownClinical Trial for Oral Formula of Vanillin and Wheat Germ Oil for Treatment of Mild and Moderate COVID-19 Vir
NCT05157139
Alexandria UniversityPhase 2 / Phase 3
WithdrawnStudy of Adalimumab or Placebo in Patients With Mild to Moderate COVID-19 (COMBAAT)
NCT04705844
Alachua Government Services, Inc.Phase 3
SuspendedFluvoxamine for Adults With Mild to Moderate COVID-19
NCT04711863
Asan Medical CenterPhase 2
CompletedA Clinical Study to Assess the Physiologic Effects of KB109 in Patients With COVID-19 on Gut Microbiota Struct
NCT04486482
Kaleido BiosciencesN/A
TerminatedEfficacy and Safety of DWJ1248 in Patients With Mild to Moderate COVID-19 Compared to the Placebo
NCT04521296
Daewoong Pharmaceutical Co. LTD.Phase 2 / Phase 3
CompletedA Clinical Study to Assess the Natural History of COVID-19 and Effects of KB109 and Supportive Self-care in Ou
NCT04414124
Kaleido BiosciencesN/A